Kyowa Pharma Set to Accelerate Beyond-the-Pill Growth after Lupin’s Divestment Deal: Chief

November 14, 2019
Indian generic maker Lupin said on November 11 that it is selling its entire stake in Kyowa Pharmaceutical Industry to Japanese private equity fund Unison Capital for 57.3 billion yen. Kyowa President Ray Tsunoda sees the move as “a major...read more